Core Viewpoint - The company, Kang En Bei, is actively expanding its international business, particularly in the field of anti-infection raw materials and traditional Chinese medicine formulations, achieving competitive advantages and making significant progress in international registrations and exports [1] Group 1: International Business Expansion - The company sells products to multiple countries, including Italy and Germany within the EU [1] - The company has developed a competitive advantage in the internationalization of anti-infection raw materials after years of effort [1] - The company is actively expanding its traditional Chinese medicine formulation business internationally [1] Group 2: Product Registration and Export - The company has completed international registrations for several products, including Plurolan tablets/capsules, Chuanlian Ning tablets, Jixuegan cream, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun export sales [1] - The company plans to adjust product forms to expand into different international markets [1]

Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun to be exported [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the "Belt and Road" initiative, to expand its international market [1]

Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun exporting [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the Belt and Road Initiative, to expand its international market [1]